Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +1.04% | +5.98% | +5.41% |
Apr. 12 | Transcript : Cognition Therapeutics, Inc. - Special Call | |
Mar. 26 | Transcript : Cognition Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 76.05M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -64M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2
x | P/E ratio 2025 * |
-1.4
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.78% |
Latest transcript on Cognition Therapeutics, Inc.
1 day | +1.04% | ||
1 week | +5.98% | ||
Current month | +7.14% | ||
1 month | +6.56% | ||
3 months | -18.75% | ||
6 months | +74.11% | ||
Current year | +5.41% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.95 | +1.04% | 55,056 |
24-04-25 | 1.93 | -3.02% | 133,328 |
24-04-24 | 1.99 | -0.50% | 114,823 |
24-04-23 | 2 | +7.53% | 136,512 |
24-04-22 | 1.86 | +1.09% | 95,131 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.41% | 76.05M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CGTX Stock